Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titres and neutralizing activity against the virus.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419441 | PMC |
| http://dx.doi.org/10.1016/j.clicom.2022.08.003 | DOI Listing |
Publication Analysis
Top Keywords
response sars-cov-2
8
sars-cov-2 patients
8
systematic review
8
endogenous antibody
4
antibody response
4
patients received
4
received monoclonal
4
monoclonal antibodies
4
antibodies covid-19
4
covid-19 systematic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!